Psoriasis: advances in pathophysiology and management

Psoriasis is an inflammatory skin disease that affects 13 of Caucasian populations and may be persistent, disfiguring and stigmatising. There is a range of severity, but even when the affected body surface area is relatively limited the impact on day-to-day activities and social interactions may be...

Full description

Saved in:
Bibliographic Details
Published in:Postgraduate medical journal 2007-11, Vol.83 (985), p.690-697
Main Authors: MacDonald, A, Burden, A D
Format: Article
Language:English
Subjects:
Administration, Oral
Administration, Topical
Alcohol
Atherosclerosis
biological
Biological and medical sciences
Cancer therapies
Cardiovascular disease
Dermatologic Agents - administration & dosage
Dermatology
Diabetes
General aspects
Genotype
Humans
Immunotherapy - methods
Lymphoma
Medical sciences
pathophysiology
Pharmaceutical industry
Prescription drugs
Psoriasis
Psoriasis - etiology
Psoriasis - therapy
Psoriasis. Parapsoriasis. Lichen
PUVA Therapy - methods
Quality of life
Review
Skin cancer
Steroids - administration & dosage
Transplants & implants
Tumor necrosis factor-TNF
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b584t-7c5e0b441c414c929541265bb00cb5597bca14610bd3bfc48d9b536113c2aeaa3
cites cdi_FETCH-LOGICAL-b584t-7c5e0b441c414c929541265bb00cb5597bca14610bd3bfc48d9b536113c2aeaa3
container_end_page 697
container_issue 985
container_start_page 690
container_title Postgraduate medical journal
container_volume 83
creator MacDonald, A
Burden, A D
description Psoriasis is an inflammatory skin disease that affects 13 of Caucasian populations and may be persistent, disfiguring and stigmatising. There is a range of severity, but even when the affected body surface area is relatively limited the impact on day-to-day activities and social interactions may be significant. An understanding of the psychological burden and an appreciation that many patients are currently dissatisfied with their management has driven the development of more effective treatment. In recent years psoriasis has been the focus of intense investigation resulting in an improved understanding of the immunopathogenesis, and the development of new, targeted biological treatments.
doi_str_mv 10.1136/pgmj.2007.061473
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2659962</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4026169301</sourcerecordid><originalsourceid>FETCH-LOGICAL-b584t-7c5e0b441c414c929541265bb00cb5597bca14610bd3bfc48d9b536113c2aeaa3</originalsourceid><addsrcrecordid>eNqFkc1v1DAQxS0EokvhzglFQpQDymLH3xyQqkABUUEPwNUaO97dLEkc7GzF_vd4lVULHOBkyfObN2_mIfSY4CUhVLwc1_12WWEsl1gQJukdtCBM6BJLLu6iBca0Knn-P0EPUtpiTKhk5D46IVIrXQm1QPwqhdhCatOrApprGJxPRTsUI0ybMG72qQ1dWO8LGJqihwHWvvfD9BDdW0GX_KPje4q-Xrz9Ur8vLz-_-1CfX5aWKzaV0nGPLWPEMcKcrjRnpBLcWoyd5VxL6yD7Jdg21K4cU422nIq8mqvAA9BT9HrWHXe2943LoyN0ZoxtD3FvArTmz8rQbsw6XJs8RWtRZYHnR4EYfux8mkzfJue7DgYfdslIJnC-hdKZPPsnKRRTirID-PQvcBt2cchnMEQqIqjQBGcKz5SLIaXoVzemCTaH7MwhO3PIzszZ5ZYnvy9723AMKwPPjgAkB90q5rTadMvpiihOZebKmWvT5H_e1CF-N0JSyc2nb7V5U3-8uuC1MnXmX8y8zY7-a_MXsK6-iw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781636910</pqid></control><display><type>article</type><title>Psoriasis: advances in pathophysiology and management</title><source>PubMed Central</source><creator>MacDonald, A ; Burden, A D</creator><creatorcontrib>MacDonald, A ; Burden, A D</creatorcontrib><description>Psoriasis is an inflammatory skin disease that affects 13 of Caucasian populations and may be persistent, disfiguring and stigmatising. There is a range of severity, but even when the affected body surface area is relatively limited the impact on day-to-day activities and social interactions may be significant. An understanding of the psychological burden and an appreciation that many patients are currently dissatisfied with their management has driven the development of more effective treatment. In recent years psoriasis has been the focus of intense investigation resulting in an improved understanding of the immunopathogenesis, and the development of new, targeted biological treatments.</description><identifier>ISSN: 0032-5473</identifier><identifier>EISSN: 1469-0756</identifier><identifier>DOI: 10.1136/pgmj.2007.061473</identifier><identifier>PMID: 17989268</identifier><language>eng</language><publisher>London: The Fellowship of Postgraduate Medicine</publisher><subject>Administration, Oral ; Administration, Topical ; Alcohol ; Atherosclerosis ; biological ; Biological and medical sciences ; Cancer therapies ; Cardiovascular disease ; Dermatologic Agents - administration &amp; dosage ; Dermatology ; Diabetes ; General aspects ; Genotype ; Humans ; Immunotherapy - methods ; Lymphoma ; Medical sciences ; pathophysiology ; Pharmaceutical industry ; Prescription drugs ; Psoriasis ; Psoriasis - etiology ; Psoriasis - therapy ; Psoriasis. Parapsoriasis. Lichen ; PUVA Therapy - methods ; Quality of life ; Review ; Skin cancer ; Steroids - administration &amp; dosage ; Transplants &amp; implants ; Tumor necrosis factor-TNF</subject><ispartof>Postgraduate medical journal, 2007-11, Vol.83 (985), p.690-697</ispartof><rights>2007 The Fellowship of Postgraduate Medicine</rights><rights>2007 INIST-CNRS</rights><rights>Copyright: 2007 2007 The Fellowship of Postgraduate Medicine</rights><rights>Copyright © 2007 The Fellowship of Postgraduate Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b584t-7c5e0b441c414c929541265bb00cb5597bca14610bd3bfc48d9b536113c2aeaa3</citedby><cites>FETCH-LOGICAL-b584t-7c5e0b441c414c929541265bb00cb5597bca14610bd3bfc48d9b536113c2aeaa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659962/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659962/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19218537$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17989268$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MacDonald, A</creatorcontrib><creatorcontrib>Burden, A D</creatorcontrib><title>Psoriasis: advances in pathophysiology and management</title><title>Postgraduate medical journal</title><addtitle>Postgrad Med J</addtitle><description>Psoriasis is an inflammatory skin disease that affects 13 of Caucasian populations and may be persistent, disfiguring and stigmatising. There is a range of severity, but even when the affected body surface area is relatively limited the impact on day-to-day activities and social interactions may be significant. An understanding of the psychological burden and an appreciation that many patients are currently dissatisfied with their management has driven the development of more effective treatment. In recent years psoriasis has been the focus of intense investigation resulting in an improved understanding of the immunopathogenesis, and the development of new, targeted biological treatments.</description><subject>Administration, Oral</subject><subject>Administration, Topical</subject><subject>Alcohol</subject><subject>Atherosclerosis</subject><subject>biological</subject><subject>Biological and medical sciences</subject><subject>Cancer therapies</subject><subject>Cardiovascular disease</subject><subject>Dermatologic Agents - administration &amp; dosage</subject><subject>Dermatology</subject><subject>Diabetes</subject><subject>General aspects</subject><subject>Genotype</subject><subject>Humans</subject><subject>Immunotherapy - methods</subject><subject>Lymphoma</subject><subject>Medical sciences</subject><subject>pathophysiology</subject><subject>Pharmaceutical industry</subject><subject>Prescription drugs</subject><subject>Psoriasis</subject><subject>Psoriasis - etiology</subject><subject>Psoriasis - therapy</subject><subject>Psoriasis. Parapsoriasis. Lichen</subject><subject>PUVA Therapy - methods</subject><subject>Quality of life</subject><subject>Review</subject><subject>Skin cancer</subject><subject>Steroids - administration &amp; dosage</subject><subject>Transplants &amp; implants</subject><subject>Tumor necrosis factor-TNF</subject><issn>0032-5473</issn><issn>1469-0756</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkc1v1DAQxS0EokvhzglFQpQDymLH3xyQqkABUUEPwNUaO97dLEkc7GzF_vd4lVULHOBkyfObN2_mIfSY4CUhVLwc1_12WWEsl1gQJukdtCBM6BJLLu6iBca0Knn-P0EPUtpiTKhk5D46IVIrXQm1QPwqhdhCatOrApprGJxPRTsUI0ybMG72qQ1dWO8LGJqihwHWvvfD9BDdW0GX_KPje4q-Xrz9Ur8vLz-_-1CfX5aWKzaV0nGPLWPEMcKcrjRnpBLcWoyd5VxL6yD7Jdg21K4cU422nIq8mqvAA9BT9HrWHXe2943LoyN0ZoxtD3FvArTmz8rQbsw6XJs8RWtRZYHnR4EYfux8mkzfJue7DgYfdslIJnC-hdKZPPsnKRRTirID-PQvcBt2cchnMEQqIqjQBGcKz5SLIaXoVzemCTaH7MwhO3PIzszZ5ZYnvy9723AMKwPPjgAkB90q5rTadMvpiihOZebKmWvT5H_e1CF-N0JSyc2nb7V5U3-8uuC1MnXmX8y8zY7-a_MXsK6-iw</recordid><startdate>20071101</startdate><enddate>20071101</enddate><creator>MacDonald, A</creator><creator>Burden, A D</creator><general>The Fellowship of Postgraduate Medicine</general><general>BMJ</general><general>Oxford University Press</general><general>BMJ Group</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20071101</creationdate><title>Psoriasis: advances in pathophysiology and management</title><author>MacDonald, A ; Burden, A D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b584t-7c5e0b441c414c929541265bb00cb5597bca14610bd3bfc48d9b536113c2aeaa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Administration, Oral</topic><topic>Administration, Topical</topic><topic>Alcohol</topic><topic>Atherosclerosis</topic><topic>biological</topic><topic>Biological and medical sciences</topic><topic>Cancer therapies</topic><topic>Cardiovascular disease</topic><topic>Dermatologic Agents - administration &amp; dosage</topic><topic>Dermatology</topic><topic>Diabetes</topic><topic>General aspects</topic><topic>Genotype</topic><topic>Humans</topic><topic>Immunotherapy - methods</topic><topic>Lymphoma</topic><topic>Medical sciences</topic><topic>pathophysiology</topic><topic>Pharmaceutical industry</topic><topic>Prescription drugs</topic><topic>Psoriasis</topic><topic>Psoriasis - etiology</topic><topic>Psoriasis - therapy</topic><topic>Psoriasis. Parapsoriasis. Lichen</topic><topic>PUVA Therapy - methods</topic><topic>Quality of life</topic><topic>Review</topic><topic>Skin cancer</topic><topic>Steroids - administration &amp; dosage</topic><topic>Transplants &amp; implants</topic><topic>Tumor necrosis factor-TNF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MacDonald, A</creatorcontrib><creatorcontrib>Burden, A D</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Postgraduate medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MacDonald, A</au><au>Burden, A D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Psoriasis: advances in pathophysiology and management</atitle><jtitle>Postgraduate medical journal</jtitle><addtitle>Postgrad Med J</addtitle><date>2007-11-01</date><risdate>2007</risdate><volume>83</volume><issue>985</issue><spage>690</spage><epage>697</epage><pages>690-697</pages><issn>0032-5473</issn><eissn>1469-0756</eissn><abstract>Psoriasis is an inflammatory skin disease that affects 13 of Caucasian populations and may be persistent, disfiguring and stigmatising. There is a range of severity, but even when the affected body surface area is relatively limited the impact on day-to-day activities and social interactions may be significant. An understanding of the psychological burden and an appreciation that many patients are currently dissatisfied with their management has driven the development of more effective treatment. In recent years psoriasis has been the focus of intense investigation resulting in an improved understanding of the immunopathogenesis, and the development of new, targeted biological treatments.</abstract><cop>London</cop><pub>The Fellowship of Postgraduate Medicine</pub><pmid>17989268</pmid><doi>10.1136/pgmj.2007.061473</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0032-5473
ispartof Postgraduate medical journal, 2007-11, Vol.83 (985), p.690-697
issn 0032-5473
1469-0756
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2659962
source PubMed Central
subjects Administration, Oral
Administration, Topical
Alcohol
Atherosclerosis
biological
Biological and medical sciences
Cancer therapies
Cardiovascular disease
Dermatologic Agents - administration & dosage
Dermatology
Diabetes
General aspects
Genotype
Humans
Immunotherapy - methods
Lymphoma
Medical sciences
pathophysiology
Pharmaceutical industry
Prescription drugs
Psoriasis
Psoriasis - etiology
Psoriasis - therapy
Psoriasis. Parapsoriasis. Lichen
PUVA Therapy - methods
Quality of life
Review
Skin cancer
Steroids - administration & dosage
Transplants & implants
Tumor necrosis factor-TNF
title Psoriasis: advances in pathophysiology and management
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A37%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Psoriasis:%20advances%20in%20pathophysiology%20and%20management&rft.jtitle=Postgraduate%20medical%20journal&rft.au=MacDonald,%20A&rft.date=2007-11-01&rft.volume=83&rft.issue=985&rft.spage=690&rft.epage=697&rft.pages=690-697&rft.issn=0032-5473&rft.eissn=1469-0756&rft_id=info:doi/10.1136/pgmj.2007.061473&rft_dat=%3Cproquest_pubme%3E4026169301%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b584t-7c5e0b441c414c929541265bb00cb5597bca14610bd3bfc48d9b536113c2aeaa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1781636910&rft_id=info:pmid/17989268&rfr_iscdi=true